BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37879402)

  • 1. Assessing the Content Validity of Preference-Based Measures in Cancer.
    Gibson AEJ; Longworth L; Bennett B; Pickard AS; Shaw JW
    Value Health; 2024 Jan; 27(1):70-78. PubMed ID: 37879402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative exploration of the content and face validity of preference-based measures within the context of dementia.
    Engel L; Bucholc J; Mihalopoulos C; Mulhern B; Ratcliffe J; Yates M; Hanna L
    Health Qual Life Outcomes; 2020 Jun; 18(1):178. PubMed ID: 32527264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
    Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
    Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
    van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
    Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.
    Herdman M; Kerr C; Pavesi M; Garside J; Lloyd A; Cubi-Molla P; Devlin N
    J Patient Rep Outcomes; 2020 Mar; 4(1):22. PubMed ID: 32219576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.
    Lorgelly PK; Doble B; Rowen D; Brazier J;
    Qual Life Res; 2017 May; 26(5):1163-1176. PubMed ID: 27830513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy.
    Xu RH; Ma B; Xin H; Zhang H; Zeng Y; Luo N; Dong D
    Health Qual Life Outcomes; 2023 Nov; 21(1):123. PubMed ID: 37968716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.
    Brazier J; Connell J; Papaioannou D; Mukuria C; Mulhern B; Peasgood T; Jones ML; Paisley S; O'Cathain A; Barkham M; Knapp M; Byford S; Gilbody S; Parry G
    Health Technol Assess; 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PubMed ID: 24857402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
    Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condition-specific preference-based measures: benefit or burden?
    Versteegh MM; Leunis A; Uyl-de Groot CA; Stolk EA
    Value Health; 2012 May; 15(3):504-13. PubMed ID: 22583461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China.
    Si Y; Li S; Xu Y; Chen G
    Qual Life Res; 2022 May; 31(5):1561-1572. PubMed ID: 34853992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study.
    Szlávicz E; Szabó Á; Kinyó Á; Szeiffert A; Bancsók T; Brodszky V; Gyulai R; Rencz F
    Qual Life Res; 2024 Jan; 33(1):101-111. PubMed ID: 37787930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
    Rowen D; Young T; Brazier J; Gaugris S
    Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of preference- and profile-based quality of life of Japanese oral cancer patients during the perioperative period measured using EQ-5D-5L and FACT-H&N.
    Aoki T; Ota Y; Izawa K; Osawa Y; Seta S; Tsuda B
    Int J Oral Maxillofac Surg; 2022 Aug; 51(8):992-999. PubMed ID: 34551875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.